Actively Recruiting
Nine-Year Study Tracking Patients With Angelman Syndrome in Belgium to Understand Their Development and Health
Led by Centre Hospitalier Universitaire de Liege · Updated on 2025-05-20
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a 9-year natural history study for patients with Angelman syndrome, a rare genetic neurodevelopmental disorder. This study is based in Belgium and aims to better understand the progression and characteristics of Angelman syndrome by following patients over time. The study plans to enroll about 30 patients and track their development using standardized assessments and questionnaires. Participants will be seen every six months for five years. During these visits, they will undergo medical reviews including general and neurological examinations, as well as vital sign measurements like height, weight, heart rate, and blood pressure. Cognitive, language, and motor skills will be assessed using various age-appropriate tools such as Bayley-IV and HINE for younger children. Quality of life and developmental progress will also be evaluated through questionnaires. Throughout the study, researchers will collect detailed data on motor function, cognitive abilities, communication skills, and overall development. Continuous movement monitoring with a device called ActiMyo will be used for two years. The study assesses multiple outcomes including functional mobility, developmental milestones, and quality of life measures. This observational study does not involve treatment but focuses on gathering information to enhance understanding of Angelman syndrome.
CONDITIONS
Brief Title
Natural History Study for Patients With Angelman Syndrome
Research Team
N
Noor Benmhammed
T
Tamara Dangouloff, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here